This hypothesis has garnered limited support, because there are mixed reports of whether these genetic variants affect cancer outcomes (Grönberg 2003), and ethnic disparities in prostate cancer are not always consistent with ethnic variation in androgen receptor genotypes (Jin et al. 2000; but see Sartor et al. 1999). This evidence concerns the gene AR and prostate cancer.